Indoco Remedies has received the Establishment Inspection Report (EIR) for its Clinical Research Organisation, AnaCipher, located at Hyderabad for the inspection carried out by the United States Food and Drug Administration (division of New Drug Bioequivalence Evaluation) from 5 August to 9 August, 2019. The inspection was successfully conducted without any observations and stands closed now.
The CRO - AnaCipher conducts Bioequivalence and Bioavailability (BA/BE) studies at its facility spread over an area of 30,000 sq. ft. with 98 beds. The CRO also has expertise in Bioanalytical work for new chemical entities (Phase I-III studies).
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
